CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma
1 clinical trials · Condition
◉ Watch CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma (NCT01854606) | Novartis Pharmaceuticals | 2013-12-05 |
Track CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.